IM Cannabis (IMCC) Gains from Equity Investments (2020 - 2026)

IM Cannabis' Gains from Equity Investments history runs 7 years deep, the most recent figure standing at -$313558.4 for Q1 2026.

• On a quarterly basis, Gains from Equity Investments fell 113.05% year-over-year to -$313558.4 in Q1 2026; TTM through Mar 2026 was $4.7 million, a 16.6% decrease from a year earlier, with the FY2024 full-year figure at $6.2 million, down 23.1% from the prior year.
• Gains from Equity Investments slipped to -$313558.4 in Q1 2026 per IMCC's latest filing, from $2.4 million in the prior quarter.
• Across five years, Gains from Equity Investments topped out at $7.4 million in Q4 2023 and bottomed at -$313558.4 in Q1 2026.
• The 5-year median for Gains from Equity Investments is $2.1 million (2022), against an average of $2.2 million.
• Across the five-year window, Gains from Equity Investments jumped 315.6% in 2022 and slumped 113.05% in 2026, its largest moves.
• Year by year, Gains from Equity Investments stood at $2.1 million in 2022, then jumped by 261.53% to $7.4 million in 2023, then plunged by 95.73% to $317121.2 in 2024, then soared by 657.74% to $2.4 million in 2025, then slumped by 113.05% to -$313558.4 in 2026.
• Per Business Quant, the three latest IMCC Gains from Equity Investments figures stand at -$313558.4 (Q1 2026), $2.4 million (Q1 2025), and $317121.2 (Q4 2024).